Atellica CH Dgn 11097526Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Digoxin (Dgn) Atellica CH - RGT 1600T · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00630414595863), received between Jul 30, 2021 and Nov 6, 2023 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Low Test Results2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 6, 2023Low Test Results; Low Test Results
A FALSELY DEPRESSED DIGOXIN (DGN) RESULT WAS OBTAINED ON A PATIENT SAMPLE ON AN ATELLICA CH 930 ANALYZER. THE ERRONEOUS RESULT WAS REPORTED TO THE PHYSICIAN(S), WHO QUESTIONED THE RESULT. THE SAMPLE WAS REPEATED ON THE INITIAL ATELLICA CH 930 ANALYZER. THE REPEAT RESULT WAS HIGHER THAN THE ERRONEOUS RESULT. THE REPEAT RESULT WAS REPORTED, AS THE CORRECT RESULT, TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY DEPRESSED DIGOXIN (DGN) RESULT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18072875 ↗MalfunctionJul 30, 2021Low Test Results; Low Test Results
SIX FALSELY DEPRESSED DIGOXIN (DGN) PATIENT SAMPLE TEST RESULTS WERE OBTAINED FROM AN ATELLICA CH 930 ANALYZER. THE INITIAL RESULTS WERE REPORTED TO THE PHYSICIAN(S). THE SAME PATIENT SAMPLES WERE REPEATED ON AN ALTERNATE ANALYZER. THE REPEAT RESULTS WERE HIGHER AND WERE REPORTED TO THE PHYSICIAN(S) AS THE CORRECT RESULTS. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY DEPRESSED DGN RESULTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12256349 ↗
Other ENZYME IMMUNOASSAY, DIGOXIN devices
- Dimension Vista® Flex® reagent cartridge DIGXN 10488927Siemens Healthcare Diagnostics Inc. · ENZYME IMMUNOASSAY, DIGOXIN15 reports
- Digoxin 20737836322Roche Diagnostics GmbH · ENZYME IMMUNOASSAY, DIGOXIN5 reports
- ONLINE TDM Digoxin 08057613190Roche Diagnostics GmbH · ENZYME IMMUNOASSAY, DIGOXIN4 reports
- Elecsys Digoxin 07027214190Roche Diagnostics GmbH · ENZYME IMMUNOASSAY, DIGOXIN1 report
- ARCHITECT 01P3227Abbott GmbH · ENZYME IMMUNOASSAY, DIGOXIN1 report
- Access Digoxin 33710Beckman Coulter, Inc. · Enzyme Immunoassay, Digoxin1 report
- Syva® Emit® 2000 Digoxin Assay 10445315Siemens Healthcare Diagnostics Inc. · ENZYME IMMUNOASSAY, DIGOXIN1 report
- ARCHITECT 1P32-25Abbott Laboratories · ENZYME IMMUNOASSAY, DIGOXIN1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page